Drug reference directory
Drug reference

Brivaracetam

Antiepileptic

Also known as Briviact

Antiepileptic
CDSCO approvedSchedule H
EXCRETION
—
not curated
INTERACTIONS
4 major
SEVERE in our sources
PREGNANCY
Women of child-bearing potential should discuss with a
FDA category + note
Top interactions
  • BuprenorphineSevereDatabaseDDInter
  • DextropropoxypheneSevereDatabaseDDInter
  • RifampicinSevereDatabaseDDInter
  • Sodium OxybateSevereDatabaseDDInter

Mechanism

Brivaracetam acts on synaptic vesicle glycoprotein 2A (SV2A). It is listed as targeting SV2A in the molecular targets of antiseizure drugs.

Indications

EpilepsySeizures

Dosing

Adult
Initially 25-50 mg BD, adjusted to response. Usual maintenance: 25-100 mg BD.
Max dose
200 mg daily (100 mg BD)

Pregnancy & lactation

Pregnancy

Women of child-bearing potential should discuss with a

Drug interactions

Buprenorphine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Dextropropoxyphene
Severe
Database

Drug interaction classified as: synergy, metabolism

Source: DDInter

Rifampicin
Severe
Database

Decreased plasma concentrations of brivaracetam, potentially leading to reduced efficacy and increased seizure frequency.

Monitor brivaracetam plasma concentrations and/or clinical response (seizure control) when co-administering with rifampicin. A dose increase of brivaracetam may be necessary. Monitor for signs of reduced efficacy.

Source: DDInter

Sodium Oxybate
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

8 additional unreviewed or low-confidence interactions hidden because their provenance or source detail is insufficient.

Related guidelines

Other Antiepileptic drugs

Ask House about Brivaracetam

Continue into a citation-backed clinical answer with the drug context already attached.

Textbook-sourced·Sources: Goodman & Gilman 14e, BNF·Updated: 2026-05-10